BIIB Oct 2024 190.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 10:13AM EDT
| Previous Close | 47.31 |
| Open | 47.31 |
| Bid | 43.20 |
| Ask | 51.20 |
| Strike | 190.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 47.31 - 47.31 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksAlzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.
ZacksThe Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
ZacksThe Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.